320 related articles for article (PubMed ID: 12802894)
21. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors.
Łastowska M; Cotterill S; Bown N; Cullinane C; Variend S; Lunec J; Strachan T; Pearson AD; Jackson MS
Genes Chromosomes Cancer; 2002 Aug; 34(4):428-36. PubMed ID: 12112532
[TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
Lastowska M; Van Roy N; Bown N; Speleman F; Roberts P; Lunec J; Strachan T; Pearson AD; Jackson MS
Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884
[TBL] [Abstract][Full Text] [Related]
23. Translocation junctions cluster at the distal short arm of chromosome 1 (1p36.1-2) in human neuroblastoma cells.
Barker PE; Savelyeva L; Schwab M
Oncogene; 1993 Dec; 8(12):3353-8. PubMed ID: 8247537
[TBL] [Abstract][Full Text] [Related]
24. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
Cunsolo CL; Bicocchi MP; Petti AR; Tonini GP
Br J Cancer; 2000 Nov; 83(10):1295-300. PubMed ID: 11044353
[TBL] [Abstract][Full Text] [Related]
25. [Tumor cytogenetics and prognosis in neuroblastoma].
Christiansen H; Lampert F
Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532
[TBL] [Abstract][Full Text] [Related]
26. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
[TBL] [Abstract][Full Text] [Related]
28. Regions syntenic to human 17q are gained in mouse and rat neuroblastoma.
Łastowska M; Chung YJ; Cheng Ching N; Haber M; Norris MD; Kees UR; Pearson AD; Jackson MS
Genes Chromosomes Cancer; 2004 Jun; 40(2):158-63. PubMed ID: 15101050
[TBL] [Abstract][Full Text] [Related]
29. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
Spieker N; Beitsma M; Van Sluis P; Chan A; Caron H; Versteeg R
Genes Chromosomes Cancer; 2001 Jun; 31(2):172-81. PubMed ID: 11319804
[TBL] [Abstract][Full Text] [Related]
30. Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.
Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; Breatnach F; O'Meara A
Cancer Genet Cytogenet; 2004 Oct; 154(1):44-51. PubMed ID: 15381371
[TBL] [Abstract][Full Text] [Related]
31. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes.
Van Roy N; Laureys G; Van Gele M; Opdenakker G; Miura R; van der Drift P; Chan A; Versteeg R; Speleman F
Eur J Cancer; 1997 Oct; 33(12):1974-8. PubMed ID: 9516836
[TBL] [Abstract][Full Text] [Related]
32. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
[TBL] [Abstract][Full Text] [Related]
33. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
[TBL] [Abstract][Full Text] [Related]
34. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.
Van Roy N; Cheng NC; Laureys G; Opdenakker G; Versteeg R; Speleman F
Eur J Cancer; 1995; 31A(4):530-5. PubMed ID: 7576960
[TBL] [Abstract][Full Text] [Related]
35. Isolation of chromosome-specific DNA sequences from an Alu polymerase chain reaction library to define the breakpoint in a patient with a constitutional translocation t(1;13) (q22;q12) and ganglioneuroblastoma.
Michalski AJ; Cotter FE; Cowell JK
Oncogene; 1992 Aug; 7(8):1595-602. PubMed ID: 1630820
[TBL] [Abstract][Full Text] [Related]
36. Variety and complexity of chromosome 17 translocations in neuroblastoma.
Schleiermacher G; Raynal V; Janoueix-Lerosey I; Combaret V; Aurias A; Delattre O
Genes Chromosomes Cancer; 2004 Feb; 39(2):143-50. PubMed ID: 14695994
[TBL] [Abstract][Full Text] [Related]
37. Molecular sublocalization and characterization of the 11;22 translocation breakpoint in a malignant rhabdoid tumor.
Newsham I; Daub D; Besnard-Guerin C; Cavenee W
Genomics; 1994 Feb; 19(3):433-40. PubMed ID: 8188285
[TBL] [Abstract][Full Text] [Related]
38. Identical chromosome 1p breakpoint abnormality in both the tumor and the constitutional karyotype of a patient with neuroblastoma.
Lampert F; Rudolph B; Christiansen H; Franke F
Cancer Genet Cytogenet; 1988 Sep; 34(2):235-9. PubMed ID: 3165695
[TBL] [Abstract][Full Text] [Related]
39. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.
Selzer RR; Richmond TA; Pofahl NJ; Green RD; Eis PS; Nair P; Brothman AR; Stallings RL
Genes Chromosomes Cancer; 2005 Nov; 44(3):305-19. PubMed ID: 16075461
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
